- Featured Product
- KD/KO Validated
PE-conjugated PLOD2-Specific Polyclonal antibody
PLOD2-Specific Polyclonal Antibody for FC (Intra)
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
FC (Intra)
Conjugate
PE Fluorescent Dye
Cat no : PE-21214
Synonyms
Validation Data Gallery
Tested Applications
Positive FC (Intra) detected in | HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
PE-21214 targets PLOD2-Specific in FC (Intra) applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | PLOD2-Specific fusion protein Ag15614 相同性解析による交差性が予測される生物種 |
Full Name | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
Calculated molecular weight | 758 aa, 85 kDa |
Observed molecular weight | 87 kDa |
GenBank accession number | BC037169 |
Gene symbol | PLOD2 |
Gene ID (NCBI) | 5352 |
Conjugate | PE Fluorescent Dye |
Excitation/Emission maxima wavelengths | 496 nm, 565 nm / 578 nm |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
PLOD2, also named as LH2, forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. It is a potential novel prognostic factor for HCC patients following surgery. Among the PLOD genes, PLOD2 contributes to cancer prognosis and angiogenesis. Several authors have reported that PLOD2 expression might provide prognostic information about malignant tumours such as glioblastoma. PLOD2 expression is a useful biomarker for the effects of antiangiogenic treatment for malignancy. (PMID:22098155). It has 2 isoforms produced by alternative splicing and seven glycosylation sites.This antibody is specific to PLOD2.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for PE PLOD2-Specific antibody PE-21214 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |